Avoid preanalytical errors such as hemolysis and QNS

Historical Context & Motivation

Clinical laboratory testing drives an estimated 70% of all medical decisions, yet the reliability of those decisions depends entirely on the quality of the specimen that arrives at the laboratory bench. The concept of preanalytical error — any mistake that occurs from the moment a test is ordered through sample collection, handling, and transport to the point of analysis — emerged as a formal area of study in the late twentieth century. Before that era, laboratories focused almost exclusively on instrument calibration and reagent quality, largely overlooking the fact that most erroneous results originated before the specimen ever entered an analyzer. Modern quality-improvement research has since demonstrated that between 46% and 68% of all laboratory errors are preanalytical in origin, making this phase the single largest source of diagnostic inaccuracy.

The central question driving this lesson is practical and urgent: How can a phlebotomist systematically prevent preanalytical errors — particularly hemolysis and quantity not sufficient (QNS) — from the bedside to the laboratory? Answering that question requires understanding the mechanisms behind each error, recognizing risk factors in real-time, and applying evidence-based collection techniques that safeguard specimen integrity.

Core Principles & Definitions

To avoid preanalytical errors, a phlebotomist must first internalize the three phases of laboratory testing. The preanalytical phase encompasses everything from test ordering, patient identification, and specimen collection through transportation and preparation for analysis. The analytical phase covers the instrument-based measurement itself, and the postanalytical phase includes result reporting and interpretation. Research consistently shows that the preanalytical phase harbors the majority of errors, making it the phase where phlebotomists exert the most direct influence on patient outcomes.

Visual Explanation — Phases of Laboratory Testing and Error Distribution

As the diagram makes clear, the preanalytical phase is not just one step among equals — it is the dominant source of laboratory error. Within that phase, hemolysis stands as the single most frequent cause of specimen rejection in clinical chemistry laboratories, sometimes exceeding 60% of all rejected samples. QNS (quantity not sufficient) follows closely, particularly in pediatric and geriatric populations where venous access is challenging. Understanding where each error type falls along the collection-to-analysis continuum empowers the phlebotomist to intervene at the correct point and apply targeted prevention strategies.

Mechanisms Behind Hemolysis and QNS

The Physiology of Hemolysis

Red blood cells are biconcave discs approximately 6–8 µm in diameter with a flexible but fragile membrane composed of a phospholipid bilayer anchored to a spectrin-based cytoskeleton. When excessive mechanical shear stress is applied — for example, by forcing blood through a small-gauge needle at high velocity, or by vigorous mixing — the membrane ruptures, and intracellular contents flood the surrounding serum or plasma. Key analytes affected include potassium (K⁺), which is roughly 23 times more concentrated inside the RBC than in plasma, as well as lactate dehydrogenase (LDH), aspartate aminotransferase (AST), phosphorus, and magnesium. Hemolysis therefore produces falsely elevated results for these analytes and can also interfere optically with spectrophotometric assays, creating a cascade of unreliable data.

Common Causes of In Vitro Hemolysis

• Needle gauge too small — Using a needle smaller than 23 gauge (e.g., 25G butterfly on an adult draw) creates excessive shear force as blood is pulled through the narrow lumen.
• Aggressive syringe aspiration — Pulling the plunger too quickly generates high negative pressure, stretching and rupturing cell membranes.
• Drawing through an IV line or heparin lock — Residual fluid dilutes the sample, and catheter walls create turbulent flow.
• Vigorous tube mixing — Shaking tubes instead of gently inverting them 8–10 times damages RBCs.
• Alcohol not fully dried — Puncturing skin before the isopropyl alcohol antiseptic has dried allows alcohol to enter the specimen, lysing cells on contact.
• Prolonged tourniquet time — Leaving the tourniquet on for more than one minute causes venous stasis, concentrating cells and increasing hemolysis risk.

Understanding QNS — Quantity Not Sufficient

A QNS specimen contains insufficient blood volume to perform the ordered tests accurately. Each test requires a minimum sample volume; for instance, a basic metabolic panel (BMP) on many analyzers requires at least 0.5 mL of serum, and a complete blood count (CBC) needs the EDTA tube filled to at least the minimum line (typically 1.0 mL in a 3 mL tube). Underfilled anticoagulant tubes pose an additional danger: the ratio of blood to anticoagulant is altered, which can falsely prolong coagulation times in citrate tubes or cause morphological artifacts in EDTA tubes. The light-blue-top citrate tube for PT/INR testing must be filled to at least 90% of the nominal draw volume; otherwise, excess citrate binds more calcium than intended, prolonging the clotting time and producing erroneous results.

Prevention Strategies — A Classification of Best Practices

Worked Example — Evaluating a Rejected Specimen

Consider the following clinical scenario: A phlebotomist draws blood from a 72-year-old patient in a medical-surgical unit. The physician has ordered a basic metabolic panel (BMP), a complete blood count (CBC), and a prothrombin time (PT/INR). The phlebotomist selects a 25-gauge butterfly needle, applies a tourniquet, cleans the site with alcohol, and immediately inserts the needle while the alcohol is still wet. After filling the gold-top SST (serum separator tube) and the lavender-top EDTA tube, the phlebotomist notices the light-blue-top citrate tube fills only halfway before the vein collapses. The tubes are vigorously shaken and sent to the laboratory.

Strengths & Limitations of Prevention Strategies

No single prevention strategy eliminates all preanalytical errors. Each approach has inherent strengths and practical limitations that phlebotomists must weigh in clinical settings. The table below compares common strategies across key performance dimensions, helping you understand when to rely on each and where additional vigilance is required.

Connection to Advanced Quality Management

The prevention of hemolysis and QNS at the point of collection is actually part of a much larger quality management framework that governs clinical laboratories. Understanding where your bedside practices connect to organizational quality systems will make you a more effective healthcare team member and prepare you for advanced roles in laboratory coordination, quality assurance, or phlebotomy supervision.

As you progress in your healthcare career, you may encounter quality improvement tools such as Lean methodology and Six Sigma applied to phlebotomy workflows. These systems quantify errors as defects per million opportunities (DPMO), and organizations achieving Six Sigma performance in preanalytical processes operate at fewer than 3.4 defects per million collections. While that level of precision is an organizational goal, it begins with individual phlebotomists who understand the science behind each error and consistently apply correct technique at the bedside.

Practice Problems

Lesson Summary